Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1349studies shown
Showing 826-850 of 1,349
CompletedNCT00150579

Efficacy and Safety of SPD465 in Adults With ADHD

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve sleep, daily rhythms, and longer-term stability.

ADHDOtherFrom 18 Years to 55 Years
Countries
Global
Sponsor
Shire
Condition
ADHD
CompletedNCT03292952

KP415 Classroom Study in Children (6-12 Years of Age) With ADHD

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Zevra Therapeutics
Condition
ADHD
CompletedNCT02255513

A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
CompletedNCT03436017

Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 15 Years
Countries
France
Sponsor
University Hospital, Tours
Condition
ADHD
CompletedNCT00202605

Safety and Efficacy of SPD465 in Adults With ADHD

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01500694

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT00763971

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

This study exists to explore whether the medication Lisdexamfetamine could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT00764868

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT00367835

SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional Symptoms

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT00734578

Efficacy and Safety of SPD503 in Combination With Psychostimulants

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT00500149

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01106430

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, Germany, Hungary, Italy, Poland, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01328756

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Germany, Hungary, Italy, Netherlands, Poland, Romania, Spain, Sweden, United Kingdom
Sponsor
Shire
Condition
ADHD